Farnesylation of lamin B1 is important for retention of nuclear chromatin during neuronal migration

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 21, 2013, Pages

  Jung, Hea Jin ^a   Nobumori, Chika ^a   Goulbourne, Chris N ^a   Tu, Yiping ^a   Lee, John M ^a   Tatar, Angelica ^a   Wu, Daniel ^a   Yoshinaga, Yuko ^b   De Jong, Pieter J ^b   Coffinier, Catherine ^a   Fong, Loren G ^a   Young, Stephen G ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CaaX motif; Genetically modified mouse models; Nucleokinesis; Posttranslational modification

Indexed keywords

LAMIN B; LAMIN B1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; CELL MIGRATION; CHROMATIN; CONTROLLED STUDY; MOUSE; NERVE CELL; NONHUMAN; NUCLEAR LAMINA; PRIORITY JOURNAL; PROTEIN FARNESYLATION; PROTEIN PROCESSING;

CAAX MOTIF; GENETICALLY MODIFIED MOUSE MODELS; NUCLEOKINESIS; POSTTRANSLATIONAL MODIFICATION;

ANIMALS; BRAIN; CELL MOVEMENT; CHROMATIN; LAMIN TYPE B; MICE; MICE, TRANSGENIC; NUCLEAR LAMINA; PROTEIN PRENYLATION;

EID: 84878133362     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1303916110     Document Type: Article

References (50)

1. Schirmer EC, Foisner R (2007) Proteins that associate with lamins: Many faces, many functions. Exp Cell Res 313(10): 2167-2179.
2. Dittmer TA, Misteli T (2011) The lamin protein family. Genome Biol 12(5):222.
3. Worman HJ, Fong LG, Muchir A, Young SG (2009) Laminopathies and the long strange trip from basic cell biology to therapy. J Clin Invest 119(7): 1825-1836.
4. Davies BS, Fong LG, Yang SH, Coffinier C, Young SG (2009) The posttranslational processing of prelamin A and disease. Annu Rev Genomics Hum Genet 10: 153-174.
5. Schafer WR, Rine J (1992) Protein prenylation: Genes, enzymes, targets, and functions. Annu Rev Genet 26: 209-237.
6. Wolda SL, Glomset JA (1988) Evidence for modification of lamin B by a product of mevalonic acid. J Biol Chem 263(13): 5997-6000.
7. Vorburger K, Kitten GT, Nigg EA (1989) Modification of nuclear lamin proteins by a mevalonic acid derivative occurs in reticulocyte lysates and requires the cysteine residue of the C-terminal CXXM motif. EMBO J 8(13): 4007-4013.
8. Otto JC, Kim E, Young SG, Casey PJ (1999) Cloning and characterization of a mammalian prenyl protein-specific protease. J Biol Chem 274(13): 8379-8382.
9. Clarke S, Vogel JP, Deschenes RJ, Stock J (1988) Posttranslational modification of the Ha-ras oncogene protein: evidence for a third class of protein carboxylmethyltransferases. Proc Natl Acad Sci USA 85(13): 4643-4647.
10. Dai Q, et al. (1998) Mammalian prenylcysteine carboxyl methyltransferase is in the endoplasmic reticulum. J Biol Chem 273(24): 15030-15034.
11. Bergo MO, et al. (2002) Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect. Proc Natl Acad Sci USA 99(20): 13049-13054.
12. Corrigan DP, et al. (2005) PrelaminA endoproteolytic processing in vitro by recombinant Zmpste24. Biochem J 387(Pt 1): 129-138.
13. Pendás AM, et al. (2002) Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice. Nat Genet 31(1): 94-99.
14. Barrowman J, Hamblet C, George CM, Michaelis S (2008) Analysis of prelamin A biogenesis reveals the nucleus to be a CaaX processing compartment. Mol Biol Cell 19(12): 5398-5408.
15. Eriksson M, et al. (2003) Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 423(6937): 293-298.
16. Fong LG, et al. (2006) A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria. Science 311(5767): 1621-1623.
17. Yang SH, Qiao X, Fong LG, Young SG (2008) Treatment with a farnesyltransferase inhibitor improves survival in mice with a Hutchinson-Gilford progeria syndrome mutation. Biochim Biophys Acta 1781(1-2): 36-39.
18. Yang SH, et al. (2006) A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation. J Clin Invest 116(8): 2115-2121.
19. Young SG, Fong LG, Michaelis S (2005) Prelamin A, Zmpste24, misshapen cell nuclei, and progeria - New evidence suggesting that protein farnesylation could be important for disease pathogenesis. J Lipid Res 46(12): 2531-2558.
20. Gordon LB, et al. (2012) Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA 109(41): 16666-16671.
21. Moir RD, Montag-Lowy M, Goldman RD (1994) Dynamic properties of nuclear lamins: Lamin B is associated with sites of DNA replication. J Cell Biol 125(6): 1201-1212.
22. Tsai MY, et al. (2006) A mitotic lamin B matrix induced by RanGTP required for spindle assembly. Science 311(5769): 1887-1893.
23. Coffinier C, et al. (2010) Abnormal development of the cerebral cortex and cerebellum in the setting of lamin B2 deficiency. Proc Natl Acad Sci USA 107(11): 5076-5081.
24. Coffinier C, et al. (2011) Deficiencies in lamin B1 and lamin B2 cause neurodevelopmental defects and distinct nuclear shape abnormalities in neurons. Mol Biol Cell 22(23): 4683-4693.
25. Kim Y, et al. (2011) Mouse B-type lamins are required for proper organogenesis but not by embryonic stem cells. Science 334(6063): 1706-1710.
26. Young SG, Jung HJ, Coffinier C, Fong LG (2012) Understanding the roles of nuclear A- and B-type lamins in brain development. J Biol Chem 287(20): 16103-16110.
27. Krohne G, Waizenegger I, Höger TH (1989) The conserved carboxy-terminal cysteine of nuclear lamins is essential for lamin association with the nuclear envelope. J Cell Biol 109(5): 2003-2011.
28. Holtz D, Tanaka RA, Hartwig J, McKeon F (1989) The CaaX motif of lamin A functions in conjunction with the nuclear localization signal to target assembly to the nuclear envelope. Cell 59(6): 969-977.
29. Hennekes H, Nigg EA (1994) The role of isoprenylation in membrane attachment of nuclear lamins. A single point mutation prevents proteolytic cleavage of the lamin A precursor and confers membrane binding properties. J Cell Sci 107(Pt 4): 1019-1029.
30. Coffinier C, et al. (2010) Direct synthesis of lamin A, bypassing prelamin a processing, causes misshapen nuclei in fibroblasts but no detectable pathology in mice. J Biol Chem 285(27): 20818-20826.
31. Troutman JM, Roberts MJ, Andres DA, Spielmann HP (2005) Tools to analyze protein farnesylation in cells. Bioconjug Chem 16(5): 1209-1217.
32. Yang SH, Andres DA, Spielmann HP, Young SG, Fong LG (2008) Progerin elicits disease phenotypes of progeria in mice whether or not it is farnesylated. J Clin Invest 118(10): 3291-3300.
33. Röber RA, Weber K, Osborn M (1989) Differential timing of nuclear lamin A/C expression in the various organs of the mouse embryo and the young animal: a developmental study. Development 105(2): 365-378.
34. Vergnes L, Péterfy M, Bergo MO, Young SG, Reue K (2004) Lamin B1 is required for mouse development and nuclear integrity. Proc Natl Acad Sci USA 101(28): 10428-10433.
35. Kitten GT, Nigg EA (1991) The CaaX motif is required for isoprenylation, carboxyl methylation, and nuclear membrane association of lamin B2. J Cell Biol 113(1): 13-23.
36. Izumi M, Vaughan OA, Hutchison CJ, Gilbert DM (2000) Head and/or CaaX domain deletions of lamin proteins disrupt preformed lamin A and C but not lamin B structure in mammalian cells. Mol Biol Cell 11(12): 4323-4337.
37. Davies BS, et al. (2010) An accumulation of non-farnesylated prelamin A causes cardiomyopathy but not progeria. Hum Mol Genet 19(13): 2682-2694.
38. Solecki DJ, Govek EE, Tomoda T, Hatten ME (2006) Neuronal polarity in CNS development. Genes Dev 20(19): 2639-2647.
39. Wynshaw-Boris A, Gambello MJ (2001) LIS1 and dynein motor function in neuronal migration and development. Genes Dev 15(6): 639-651.
40. Zhang X, et al. (2009) SUN1/2 and Syne/Nesprin-1/2 complexes connect centrosome to the nucleus during neurogenesis and neuronal migration in mice. Neuron 64(2): 173-187.
41. Lombardi ML, et al. (2011) The interaction between nesprins and sun proteins at the nuclear envelope is critical for force transmission between the nucleus and cytoskeleton. J Biol Chem 286(30): 26743-26753.
42. Coffinier C, Fong LG, Young SG (2010) LINCing lamin B2 to neuronal migration: Growing evidence for cell-specific roles of B-type lamins. Nucleus 1(5): 407-411.
43. Zhang FL, Casey PJ (1996) Protein prenylation: Molecular mechanisms and functional consequences. Annu Rev Biochem 65: 241-269.
44. Liu P, Jenkins NA, Copeland NG (2003) A highly efficient recombineering-based method for generating conditional knockout mutations. Genome Res 13(3): 476-484.
45. Yang SH, et al. (2011) An absence of both lamin B1 and lamin B2 in keratinocytes has no effect on cell proliferation or the development of skin and hair. Hum Mol Genet 20(18): 3537-3544.
46. Steinert P, Zackroff R, Aynardi-Whitman M, Goldman RD (1982) Isolation and characterization of intermediate filaments. Methods Cell Biol 24: 399-419.
47. Fong LG, et al. (2004) Heterozygosity for Lmna deficiency eliminates the progeria-like phenotypes in Zmpste24-deficient mice. Proc Natl Acad Sci USA 101(52): 18111-18116.
48. Jung HJ, et al. (2012) Regulation of prelamin A but not lamin C by miR-9, a brainspecific microRNA. Proc Natl Acad Sci USA 109(7):E423-E431.
49. Dechat T, et al. (2007) Alterations in mitosis and cell cycle progression caused by a mutant lamin A known to accelerate human aging. Proc Natl Acad Sci USA 104(12): 4955-4960.
50. Mastronarde DN (1997) Dual-axis tomography: An approach with alignment methods that preserve resolution. J Struct Biol 120(3): 343-352.